Harrow, Inc. - Common Stock (HROW)

Harrow Inc is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of innovative ophthalmic solutions

The company aims to improve patient outcomes through its portfolio of prescription eye medications, which are designed to address various ocular conditions and diseases. Harrow combines its expertise in drug formulation and compounding with a commitment to enhancing the quality of life for patients suffering from eye-related issues, positioning itself as a leader within the ophthalmic pharmaceutical sector. Through strategic partnerships and a dedication to research and development, Harrow strives to expand its offerings and address unmet medical needs in the eye care market.